![Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41391-023-00675-1/MediaObjects/41391_2023_675_Fig1_HTML.png)
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
![Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-023-42088-z/MediaObjects/41598_2023_42088_Fig1_HTML.png)
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
![Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study](https://www.frontiersin.org/files/Articles/832835/fonc-12-832835-HTML/image_m/fonc-12-832835-t001.jpg)
Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
![Cepheid on X: "Don't miss Dr. Cancel-Tassin's #EAU19 poster presentation on March 17 at 2pm (topic 8.4) about the management of non-muscle invasive # bladdercancer using Cepheid's Xpert Bladder Cancer Monitor test and Cepheid on X: "Don't miss Dr. Cancel-Tassin's #EAU19 poster presentation on March 17 at 2pm (topic 8.4) about the management of non-muscle invasive # bladdercancer using Cepheid's Xpert Bladder Cancer Monitor test and](https://pbs.twimg.com/media/D1rY08aU8AEB2My.jpg:large)
Cepheid on X: "Don't miss Dr. Cancel-Tassin's #EAU19 poster presentation on March 17 at 2pm (topic 8.4) about the management of non-muscle invasive # bladdercancer using Cepheid's Xpert Bladder Cancer Monitor test and
![Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers](https://pub.mdpi-res.com/life/life-12-00395/article_deploy/html/images/life-12-00395-g001.png?1646809342)
Life | Free Full-Text | Proteomics for Early Detection of Non-Muscle-Invasive Bladder Cancer: Clinically Useful Urine Protein Biomarkers
![Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports](https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41598-022-23111-1/MediaObjects/41598_2022_23111_Fig1_HTML.png)
Xpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial) | Scientific Reports
![The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors](https://sciendo-parsed.s3.eu-central-1.amazonaws.com/647355f34e662f30ba53aa8d/cover-image.jpg)
The performance of the Xpert Bladder Cancer Monitor Test and voided urinary cytology in the follow-up of urinary bladder tumors
![Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance: First Experiences from a novel mRNA-based Urine Test Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance: First Experiences from a novel mRNA-based Urine Test](https://abstracts.mirrorsmed.org/sites/default/files/520-0.jpg)
Xpert Bladder Cancer Monitor for Bladder Cancer Surveillance: First Experiences from a novel mRNA-based Urine Test
![Pooled analysis of Xpert Bladder Cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma | World Journal of Surgical Oncology | Full Text Pooled analysis of Xpert Bladder Cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma | World Journal of Surgical Oncology | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12957-021-02154-0/MediaObjects/12957_2021_2154_Fig6_HTML.png)
Pooled analysis of Xpert Bladder Cancer based on the 5 mRNAs for rapid diagnosis of bladder carcinoma | World Journal of Surgical Oncology | Full Text
![Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/832835/832835_Thumb_400.jpg)
Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
![Cancers | Free Full-Text | Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted? Cancers | Free Full-Text | Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?](https://pub.mdpi-res.com/cancers/cancers-15-03683/article_deploy/html/images/cancers-15-03683-g001.png?1689779507)
Cancers | Free Full-Text | Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?
![Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS) Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS)](https://media.springernature.com/lw150/springer-static/cover/journal/345/38/9.jpg?as=jpg)
Clinical performance of Xpert Bladder Cancer (BC) Monitor, a mRNA-based urine test, in active surveillance (AS) patients with recurrent non-muscle-invasive bladder cancer (NMIBC): results from the Bladder Cancer Italian Active Surveillance (BIAS)
Performance of cytology, Xpert® Bladder Cancer Monitor and combination... | Download Scientific Diagram
![Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update - Carolina D'Elia, Decio M. Folchini, Christine Mian, Esther Hanspeter, Christine Schwienbacher, Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update - Carolina D'Elia, Decio M. Folchini, Christine Mian, Esther Hanspeter, Christine Schwienbacher,](https://journals.sagepub.com/cms/10.1177/1756287221997183/asset/images/large/10.1177_1756287221997183-fig2.jpeg)
Diagnostic value of Xpert® Bladder Cancer Monitor in the follow-up of patients affected by non-muscle invasive bladder cancer: an update - Carolina D'Elia, Decio M. Folchini, Christine Mian, Esther Hanspeter, Christine Schwienbacher,
![Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study](https://www.frontiersin.org/files/Articles/832835/fonc-12-832835-HTML/image_m/fonc-12-832835-g001.jpg)
Frontiers | Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under “Active Surveillance” for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study
![Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer - ScienceDirect Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143920303355-gr1.jpg)
Prospective Validation of Clinical Usefulness of a Novel mRNA-based Urine Test (Xpert® Bladder Cancer Monitor) for surveillance in Non Muscle Invasive Bladder Cancer - ScienceDirect
![PDF] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma | Semantic Scholar PDF] Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/a757ee8a0139076c80a16a1a476318d6fb9daf94/3-Figure1-1.png)